VIDIUM
LIVE

Serial Number

97151014

Owner

The Translational Genomics Research Institute

Attorney

Bradley P. Hartman

First Use Date

May 26, 2020

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

VIDIUM Trademark

Serial Number: 97151014 • Registration: 6889622

VIDIUM is a trademark filed by The Translational Genomics Research Institute on December 1, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

The Translational Genomics Research Institute (42 trademarks)

Phoenix, AZ 85004

Entity Type: 03

Trademark Details

Filing Date

December 1, 2021

Registration Date

November 1, 2022

First Use Anywhere

May 26, 2020

First Use in Commerce

June 4, 2020

Published for Opposition

August 16, 2022

Goods & Services

Veterinary testing for diagnostic or treatment purposes in the field of cancer research; Veterinary diagnostic testing, monitoring and reporting services; Veterinary evaluation services; Veterinary monitoring services; Veterinary diagnostic, prognostic and theranostic screening and testing; Collection and preservation of DNA for veterinary diagnostic or treatment purposes; Consulting services in the nature of providing veterinary information; Consulting services in the field of healthcare and cancer diagnoses; Providing a website featuring health and healthcare information related to cancer research, testing and screening; Genetic testing for veterinary diagnostic or treatment purposes; Providing information in the field of screening, diagnosis and treatment for veterinary diagnostic and treatment purposes; Genetic testing for veterinary diagnostic purposes; Genomic testing for veterinary diagnostic purposes

Veterinary and scientific research in the field of genetic testing and diagnosis and treatment of veterinary conditions; Development of tests and laboratory testing in the field of genetics and animal disease; Scientific research consulting in the field of genetics, genomics, DNA sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Veterinary and scientific research, development and consulting in the field of oncology; Veterinary and scientific research and consulting in the fields of genomics and generation sequencing; Veterinary and scientific research in the field of cancer treatment and diagnosis; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for scientific research purposes; Veterinary and scientific research relating to the design and development of cancer treatment therapies; Conducting clinical and pre-clinical trials for others; Conducting educational research for others on the subjects of biology, molecular biology, genetics, genomics, DNA sequencing, and bioinformatics for scientific purposes; Consulting services in the field of veterinary research of veterinary and genetic conditions; Diagnostic services in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids for scientific purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; DNA-sequencing for scientific research purposes; Targeted pharmaceutical drug development services; Genotyping for scientific purposes; Gene screening for scientific purposes; Gene isolation and gene expression analysis for scientific research purposes; Gene mapping for scientific purposes; Gene analysis and biomarker discovery for scientific research purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2022 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 1, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 1, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 16, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 16, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 27, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2022 CNSA
ASSIGNED TO EXAMINER
Jun 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP